141 related articles for article (PubMed ID: 29695398)
21. LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.
Zhou X; Sang M; Liu W; Gao W; Xing E; Lü W; Xu Y; Fan X; Jing S; Shan B
Life Sci; 2012 Sep; 91(9-10):358-63. PubMed ID: 22906635
[TBL] [Abstract][Full Text] [Related]
22. Rsu1 contributes to cell adhesion and spreading in MCF10A cells via effects on P38 map kinase signaling.
Kim YC; Gonzalez-Nieves R; Cutler ML
Cell Adh Migr; 2015; 9(3):227-32. PubMed ID: 25482629
[TBL] [Abstract][Full Text] [Related]
23. Mapping the integrin-linked kinase interactome using SILAC.
Dobreva I; Fielding A; Foster LJ; Dedhar S
J Proteome Res; 2008 Apr; 7(4):1740-9. PubMed ID: 18327965
[TBL] [Abstract][Full Text] [Related]
24. Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma.
Duffy DJ; Krstic A; Halasz M; Schwarzl T; Fey D; Iljin K; Mehta JP; Killick K; Whilde J; Turriziani B; Haapa-Paananen S; Fey V; Fischer M; Westermann F; Henrich KO; Bannert S; Higgins DG; Kolch W
Oncotarget; 2015 Dec; 6(41):43182-201. PubMed ID: 26673823
[TBL] [Abstract][Full Text] [Related]
25. Dissecting integrin-dependent regulation of neural stem cell proliferation in the adult brain.
Porcheri C; Suter U; Jessberger S
J Neurosci; 2014 Apr; 34(15):5222-32. PubMed ID: 24719101
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15).
Gkretsi V; Louca M; Stylianou A; Minadakis G; Spyrou GM; Stylianopoulos T
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621163
[TBL] [Abstract][Full Text] [Related]
27. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
28. LIM domain only 1: an oncogenic transcription cofactor contributing to the tumorigenesis of multiple cancer types.
Zhao GF; Du LQ; Zhang L; Jia YC
Chin Med J (Engl); 2021 Apr; 134(9):1017-1030. PubMed ID: 33870932
[TBL] [Abstract][Full Text] [Related]
29. Molecular dissection of the ILK-PINCH-parvin triad reveals a fundamental role for the ILK kinase domain in the late stages of focal-adhesion maturation.
Stanchi F; Grashoff C; Nguemeni Yonga CF; Grall D; Fässler R; Van Obberghen-Schilling E
J Cell Sci; 2009 Jun; 122(Pt 11):1800-11. PubMed ID: 19435803
[TBL] [Abstract][Full Text] [Related]
30. APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.
Li Z; Abraham BJ; Berezovskaya A; Farah N; Liu Y; Leon T; Fielding A; Tan SH; Sanda T; Weintraub AS; Li B; Shen S; Zhang J; Mansour MR; Young RA; Look AT
Leukemia; 2017 Oct; 31(10):2057-2064. PubMed ID: 28260788
[TBL] [Abstract][Full Text] [Related]
31. Upregulated LMO1 in prostate cancer acts as a novel coactivator of the androgen receptor.
Gu H; Liu T; Cai X; Tong Y; Li Y; Wang C; Li F
Int J Oncol; 2015 Dec; 47(6):2181-7. PubMed ID: 26459575
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic role of miR-26a on cardiaorenal injury in mice model of angiotensin-II induced chronic kidney disease through inhibition of LIMS1/ILK pathway.
Ni W; Zhao Y; Shen J; Yin Q; Wang Y; Li Z; Tang T; Wen Y; Zhang Y; Jiang W; Jiang L; Wei J; Gan W; Zhang A; Zhou X; Wang B; Liu BC
Chin Med J (Engl); 2024 Mar; ():. PubMed ID: 38445356
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional induction of the human asparagine synthetase gene during the unfolded protein response does not require the ATF6 and IRE1/XBP1 arms of the pathway.
Gjymishka A; Su N; Kilberg MS
Biochem J; 2009 Feb; 417(3):695-703. PubMed ID: 18840095
[TBL] [Abstract][Full Text] [Related]
34. Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia.
Oram SH; Thoms J; Sive JI; Calero-Nieto FJ; Kinston SJ; Schütte J; Knezevic K; Lock RB; Pimanda JE; Göttgens B
Leukemia; 2013 Jun; 27(6):1348-57. PubMed ID: 23302769
[TBL] [Abstract][Full Text] [Related]
35. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ
Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297
[TBL] [Abstract][Full Text] [Related]
36. Effects of lentivirus-mediated shRNA targeting integrin-linked kinase on oral squamous cell carcinoma in vitro and in vivo.
Que L; Zhao D; Tang XF; Liu JY; Zhang XY; Zhan YH; Zhang L
Oncol Rep; 2016 Jan; 35(1):89-98. PubMed ID: 26531674
[TBL] [Abstract][Full Text] [Related]
37. MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.
Xue C; Yu DM; Gherardi S; Koach J; Milazzo G; Gamble L; Liu B; Valli E; Russell AJ; London WB; Liu T; Cheung BB; Marshall GM; Perini G; Haber M; Norris MD
Oncotarget; 2016 Aug; 7(34):54937-54951. PubMed ID: 27448979
[TBL] [Abstract][Full Text] [Related]
38. ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.
Bui CB; Le HK; Vu DM; Truong KD; Nguyen NM; Ho MAN; Truong DQ
Mol Carcinog; 2019 Nov; 58(11):1998-2007. PubMed ID: 31365169
[TBL] [Abstract][Full Text] [Related]
39. ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation.
Hausmann C; Temme A; Cordes N; Eke I
Oncotarget; 2015 Oct; 6(33):34592-605. PubMed ID: 26460618
[TBL] [Abstract][Full Text] [Related]
40. LIM-domain-only proteins: multifunctional nuclear transcription coregulators that interacts with diverse proteins.
Sang M; Ma L; Sang M; Zhou X; Gao W; Geng C
Mol Biol Rep; 2014 Feb; 41(2):1067-73. PubMed ID: 24379077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
